₹1,30,000 / 1000 shares
Issue Date
01 Dec - 3 Dec'25
Investment/lot
₹1,30,000
Price Range
₹123 - ₹130
Lot Size
1000
IPO Size
₹24.1 Cr
Listing On
8 Dec'25
Issue Price
₹130
Listed Price
₹ 201
Retail Gain/Listing Gain
▲54.62%
Start date
01/12/2025
End date
03/12/2025
Allotment of bids
04/12/2025
Refund Initiation
05/12/2025
Listing on exchange
08/12/2025
(Last updated on 03 Dec 2025 04:45 PM)
| Day | Total | QIB | Retail | NII |
|---|---|---|---|---|
Day 1 01-Dec-2025 | 14.4x | 3.52x | 17.89x | 19.03x |
Day 2 02-Dec-2025 | 75.85x | 6.86x | 95.47x | 109.52x |
Day 3 03-Dec-2025 | 403.23x | 155.91x | 456x | 554.33x |
| Category | Subscription Rate |
|---|---|
Non-Institutional (HNI) | 554.76x |
Qualified Institutions | 155.91x |
Retail | 460.86x |
Total Subscription | 405.62x |
The 100% book building issue of Ravelcare comprises a fresh issue of aggregating up to 18,54,000 equity shares. There’s no offer for sale in this IPO. The price band is ₹123 to ₹130 per share and the lot size is 1000.
The Ravelcare IPO opens on December 1, 2025 and closes on December 3, 2025. The allotment of shares will take place on December 4, 2025. The credit of shares to the Demat account will take place on December 5, 2025. The initiation of refunds will take place on December 5, 2025. The listing of shares will take place on December 8, 2025.
Ravelcare operates through a digital first distribution model in the beauty and personal care segment (“BPC”) offering a range of haircare, skincare, and bodycare products. Its current operations are built around a direct-to-consumer (D2C) approach, supported by e-commerce and data-driven product development processes.
The company proposes to utilise the IPO proceeds for:
| Application | Lots | Shares | Amount in INR |
|---|---|---|---|
Individual Investors (Retail) (Min) | 2 | 2000 | 2,60,000 |
Individual Investors (Retail) (Max) | 2 | 2000 | 2,60,000 |
S-HNI (Min) | 3 | 3000 | 3,90,000 |
S-HNI (Max) | 7 | 7000 | 9,10,000 |
B-HNI (Min) | 8 | 8000 | 10,40,000 |
| Investor Category | Shares Offered |
|---|---|
QIBs | Not more than 50% of the net issue |
Non-institutional Investors | Not less than 15% of the net issue |
Retail Individual Investors | Not less than 35% of the net issue |
The beauty and personal care market in India encompass the following sub-segments: Skincare, Oral Care, Hair Care, Men's Grooming, Makeup & Cosmetics, Fragrance, and Bath & Shower. The Indian beauty and personal care market is expected to grow at a CAGR of 9.6% from 2021 to 2026. Note that over the last decade, India has seen consistent growth in the personal care and cosmetics market with increasing shelf space in boutiques and retail stores across the country.
The Indian cosmetics industry is majorly categorised into skin care, hair care, oral care, fragrances, and colour cosmetics segments. The overall market share is expected to grow to US$ 20 billion by 2025 with a Compound Annual Growth Rate (CAGR) of 25%. On the other hand, India’s beauty, cosmetics and grooming market is expected to reach US$ 20 billion by 2025. The market share of organised and unorganised will be 44:55 by 2025 from the existing ratio of 25:75.
Ravelcare specialises in personalised hair care, skincare and body care products within the beauty and personal care industry. Its core mission is to redefine beauty standards by offering bespoke products meticulously crafted to meet the needs and preferences of customers. It focuses on harnessing top-tier ingredients, cutting-edge product research, and direct customer feedback to curate exceptional formulations that deliver transformative results.
Its dedication to personalised beauty regimens empowers individuals to embrace their distinctiveness and enhances their self-assurance. It aims to foster a movement towards personalised self-care by revolutionising how people perceive and engage with beauty, thereby enhancing the overall customer experience.
There are no listed companies in India that are engaged in the business segment in which Ravelcare operates or of a comparable size to that of it. Accordingly, it is not possible to provide an industry comparison in relation to Ravelcare.
Anchor Investor Bidding Date
Anchor portion of the IPO opens for bidding on November 28, 2025.
IPO Registrar and Book Running Lead Manager
Specialising in personalised haircare, skincare and body care products, Ravelcare business model focuses on a direct-to-consumer (D2C) approach, strategically leveraging e-commerce platforms and digital channels to engage with customers directly. Its core business is to deliver tailored haircare, skincare, and body care products.
The revenue of operations of Ravelcare increased from ₹3.4936 crores in FY 23 to ₹24.9789 crores in FY 25. Its EBITDA margin increased from 14.51% in FY 23 to 27.30% in FY 25, while PAT margin increased from 11.87% in FY 23 to 21.04% in FY 25. Diversified customer base having a wide geographic presence and product innovations have helped the company grow over the years.
Ravelcare has sales across India, from north to south and from east to west. As on date of the company’s draft red herring prospectus (DRHP), it had served 2,02,861 customers on Pan India basis. Also, as on the date of the DRHP, the company had 11 master SKUs and 40 child SKUs.
It introduced 4 SKUs and 3 SKUs in haircare & skincare range respectively during the financial year 2023-2024. It introduced 4 SKUs and 1 SKU in haircare & skincare range respectively in the first quarter of financial year 2024-25.
| Parameter | FY25 | FY24 | FY23 |
|---|---|---|---|
Total Income | 25.2980 | 22.2788 | 3.4937 |
Profit / (Loss) Before Tax | 7.0402 | 6.8088 | 0.5064 |
Profit /(Loss) After Tax | 5.2552 | 5.0241 | 0.4147 |
EBITDA | 6.8198 | 6.6411 | 0.5070 |
EPS in ₹ | 10.50 | 10.04 | 0.83 |
| Parameter | FY25 | FY24 | FY23 |
|---|---|---|---|
Profit / (Loss) Before Tax | 7.0402 | 6.8088 | 0.5064 |
Net Cash from Operating Activities | (0.5543) | 6.4167 | 1.0004 |
Net Cash (Used in) Investing Activities | 1.1811 | (6.9167) | (0.0116) |
Net Cash (Used in) / Generated from Financing Activities | (0.0381) | (0.3672) | (0.0113) |
Closing Balance of Cash and Cash Equivalents | 0.7045 | 0.1158 | 0.9831 |
To apply for this IPO:
This article is for informational purposes only and does not constitute financial advice. It is not produced by the desk of the Kotak Securities Research Team, nor is it a report published by the Kotak Securities Research Team. The information presented is compiled from several secondary sources available on the internet and may change over time. Investors should conduct their research and consult with financial professionals before making any investment decisions. Read the full disclaimer here.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing. Please read the SEBI-prescribed Combined Risk Disclosure Document before investing. Brokerage will not exceed SEBI’s prescribed limit.
Ravelcare IPO will be allotted on 2025-12-04.
Ravelcare IPO will list on 2025-12-08.
₹24.1 Cr is the issue size of Ravelcare IPO.
The minimum lot size is 1000 shares and the investment required is ₹130000.
The price band of Ravelcare IPO is ₹123 to ₹130.
You can read more about Ravelcare and its IPO from the company’s red herring prospectus (RHP) here.
The IPO of Ravelcare consists of a fresh issue of up to 18,54,000 equity shares, aggregating up to ₹24.10 crores. It has no offer for sale.
The IPO opens for bidding on December 1, 2025 and closes on December 3, 2025.
The lot size of shares in the IPO is 1000.
Ayush Mahesh Varma is the Chairman and MD of Ravelcare.
You can read more about Ravelcare and its IPO from the company’s red herring prospectus here.